Shilpa Gadgil

AVP, Head of CDMO development, Head of Advanced Analytical Techniques at Enzene Biosciences Ltd.

Speaker

Shilpa has a PhD in Biochemistry from University of Tennessee, Memphis. In her current role at Enzene, Shilpa heads the process and analytical department and CDMO development that is responsible for end to end product development from cloning to drug product. She is also the lead for multiple Biosimilar products being developed for the EU and US markets. Shilpa has vast experience in the field of diabetes and autoimmune diseases from Universities such as UMass, UCLA etc. with over 30 publications in the peer reviewed journals.